SFB 1530 | CRC 1530's new study by Kristie Bariboloka of project A04 in the group of Alessandro Annibaldi reveals a major weak spot in aggressive lymphoma: the protein cFLIP helps cancer cells evade death. Targeting cFLIP could re activate cell death and open the door to new therapies for hard to treat diffuse large B cell lymphoma (DLBCL). We couldnt wait to share this ahead of print, so here goes.
